Cel Sci Story

<div class='circular--portrait' style='background:#4E8BFC;color: #ffffff;font-size:4em;'>CS</div>
CVM -- USA Stock  

USD 14.49  0.48  3.21%

Cel Sci Price to Book Value is relatively stable at the moment as compared to the past year. The company's current Price to Book Value is estimated at 71.54. Price to Sales Ratio is expected to hike to 505.12 this year, although the value of Earnings Before Interest Taxes and Depreciation Amortization EBITDA will most likely fall to (19.1 M). In this article, we will summarize Cel Sci as a potential position in addition to your existing holdings. We will summarize why it could be a game-changer for Cel Sci stakeholders.
Published over a month ago
View all stories for Cel Sci | View All Stories
Is Cel Sci (NYSEMKT:CVM) outlook positive for January 2021?
On a scale of 0 to 100, Cel Sci holds a performance score of 3. The firm shows a Beta (market volatility) of -0.8606, which signifies possible diversification benefits within a given portfolio. Let's try to break down what Cel Sci's beta means in this case. As the market becomes more bullish, returns on owning Cel Sci are expected to decrease slowly. On the other hand, during market turmoil, Cel Sci is expected to outperform it slightly. Although it is vital to follow Cel Sci historical returns, it is good to be conservative about what you can do with the information regarding equity current trending patterns. The philosophy towards foreseeing future performance of any stock is to evaluate the business as a whole together with its past performance, including all available fundamental and technical indicators. By analyzing Cel Sci technical indicators, you can presently evaluate if the expected return of 0.27% will be sustainable into the future. Please makes use of Cel Sci downside deviation, jensen alpha, as well as the relationship between the Jensen Alpha and downside variance to make a quick decision on whether Cel Sci price patterns will revert.
There are currently many different techniques concerning forecasting the market as a whole as well as predicting future values of individual securities such as Cel Sci. Regardless of method or technology, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.

Predictive Modules for Cel Sci

Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Cel Sci's stock price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Cel Sci in the context of predictive analytics.
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Cel Sci. Your research has to be compared to or analyzed against Cel Sci's peers to derive any actionable benefits. When done correctly, Cel Sci's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Cel Sci.

How important is Cel Sci's Liquidity

Cel Sci financial leverage refers to using borrowed capital as a funding source to finance Cel Sci ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. Cel Sci financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Please check the breakdown between Cel Sci's total debt and its cash.

How Cel Sci utilizes its cash?

To perform a cash flow analysis of Cel Sci, investors first need to understand how to read the cash flow statement. A cash flow statement shows the amount of cash Cel Sci is receiving and how much cash it distributes out in a given period. The Cel Sci cash flow statement breaks down these inflows and outflows into different buckets, including operating activities, investing activities, and financing activities. Cel Sci Net Cash Flow from Operations is relatively stable at the moment as compared to the past year. The company's current value of Net Cash Flow from Operations is estimated at (18.95 Million)

Another Deeper Perspective

Cel Sci shows above-average downside volatility for the selected time horizon. We advise investors to inspect Cel Sci further and ensure that all market timing and asset allocation strategies are consistent with the estimation of Cel Sci future alpha.

Returns Breakdown

Return on Assets(0.81)
Return on Equity(10.51)
Return Capital(0.97)
Return on Sales(36.86)

Over 3 percent hike for Cel Sci. What does it mean for stakeholders?

The downside variance is down to 17.07 as of today. Cel Sci shows above-average downside volatility for the selected time horizon. We advise investors to inspect Cel Sci further and ensure that all market timing and asset allocation strategies are consistent with the estimation of Cel Sci future alpha.

Our Takeaway on Cel Sci Investment

While some other firms under the biotechnology industry are still a bit expensive, Cel Sci may offer a potential longer-term growth to stakeholders. The inconsistency in the assessment between current Cel Sci valuation and our trade advice on Cel Sci is due to the recent market swings and your selection of investing horizon. Please use our equity advice module to run different scenarios to ensure your current risk level and investment horizon are fully reflective of your current investing preferences in regards to Cel Sci.

About Contributor

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Vlad Skutelnik do not own shares of Cel Sci. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to editors@macroaxis.com